Literature DB >> 1915188

Spirometric abnormalities among welders.

S K Rastogi1, B N Gupta, T Husain, N Mathur, S Srivastava.   

Abstract

A group of manual welders (N = 57) engaged in gas welding joint faces of moulded brasswares, age group 13-60 years (mean: 29.2 +/- 1.37 years), having a mean exposure period of 12.4 +/- 1.12 years (range: 1-35 years) were subjected to spirometry to evaluate the prevalence of spirometric abnormalities. The findings were compared with those obtained from a reference group (N = 131) (mean age: 31.2 +/- 1.35 years) engaged in nonwelding jobs such as packing, labelling, and transportation of the finished brassware articles. The welders showed a significantly higher prevalence of respiratory impairment (28.0%) than that observed among the unexposed controls (6.1%) (P less than 0.001), as a result of exposure to welding gases which comprised fine particles of lead, zinc, chromium, and manganese. This occurred despite the lower concentration of the pollutants at the work place. In the exposed group, the smoking welders showed a prevalence of respiratory impairment significantly higher than that observed in the nonsmoking welders (40.0 vs 18.7%) (P less than 0.10). A similar trend was observed in the control group indicating that smoking had a deteriorating effect on spirometric tests. The results of the pulmonary function tests showed a predominantly restrictive type of pulmonary impairment (12.3%) followed by a mixed ventilatory defect (8.7%) among the welders. The effect of age on pulmonary impairment was not discernible either in the exposed or unexposed group. The analysis of data in relation to duration of exposure showed significant correlation between the prevalence of respiratory abnormalities and length of exposure. Welders exposed for over 10 years showed a prevalence of respiratory abnormalities significantly higher than those exposed for less than 10 years (44.4 vs 13.3%) (P less than 0.01) thereby showing that occupational exposure to welding fumes resulted in increased prevalence of pulmonary impairment in the welders. Smoking also had a contributory role thereby suggesting an interaction between smoking and welding exposure on the prevalence of pulmonary impairment in the welders engaged in brassware industries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915188     DOI: 10.1016/s0013-9351(05)80105-7

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  6 in total

1.  Is metal fume fever a determinant of welding related respiratory symptoms and/or increased bronchial responsiveness? A longitudinal study.

Authors:  M El-Zein; C Infante-Rivard; J-L Malo; D Gautrin
Journal:  Occup Environ Med       Date:  2005-10       Impact factor: 4.402

2.  Prevalence and association of welding related systemic and respiratory symptoms in welders.

Authors:  M El-Zein; J-L Malo; C Infante-Rivard; D Gautrin
Journal:  Occup Environ Med       Date:  2003-09       Impact factor: 4.402

3.  Total fume and metal concentrations during welding in selected factories in Jeddah, Saudi Arabia.

Authors:  Mansour Ahmed Balkhyour; Mohammad Khalid Goknil
Journal:  Int J Environ Res Public Health       Date:  2010-07-22       Impact factor: 3.390

4.  Occupational safety measures and morbidity among welders in Vellore, Southern India.

Authors:  Vijay Alexander; Kulandaipalayam Natarajan C Sindhu; Pradeep Zechariah; Abigail Veravolu Resu; Suryanarayan Rajendran Nair; Deepthi Kattula; Venkata Raghava Mohan; Reginald George Alex T
Journal:  Int J Occup Environ Health       Date:  2016-09-28

5.  Chronic effects of welding exposure on pulmonary function tests and respiratory symptoms.

Authors:  O Ozdemir; N Numanoğlu; U Gönüllü; I Savaş; D Alper; H Gürses
Journal:  Occup Environ Med       Date:  1995-12       Impact factor: 4.402

6.  A prospective study of decline in lung function in relation to welding emissions.

Authors:  Sigve W Christensen; Jens Peter Bonde; Oyvind Omland
Journal:  J Occup Med Toxicol       Date:  2008-02-26       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.